Caribou Biosciences Inc’s filing revealed that its Chief Legal Officer MCCLUNG BARBARA G unloaded Company’s shares for reported $4811.0 on Feb 21 ’25. In the deal valued at $1.35 per share,3,564 shares were sold. As a result of this transaction, MCCLUNG BARBARA G now holds 443,502 shares worth roughly $0.57 million.
Then, Khan Ruhi Ahmad sold 3,564 shares, generating $4,811 in total proceeds. Upon selling the shares at $1.35, the Chief Business Officer now owns 66,936 shares.
Before that, Kanner Steven sold 3,564 shares. Caribou Biosciences Inc shares valued at $4,811 were divested by the Chief Scientific Officer at a price of $1.35 per share. As a result of the transaction, Kanner Steven now holds 431,556 shares, worth roughly $0.55 million.
Evercore ISI downgraded its Caribou Biosciences Inc [CRBU] rating to an In-line from a an Outperform in a research note published on June 03, 2024; the price target was decreased to $3 from $13. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in early November with a ‘”a Neutral”‘ rating. Evercore ISI began covering CRBU with “an Outperform” recommendation on October 31, 2023. Truist started covering the stock on July 11, 2023. It rated CRBU as “a Buy”.
Price Performance Review of CRBU
On Friday, Caribou Biosciences Inc [NASDAQ:CRBU] saw its stock fall -2.29% to $1.28. Over the last five days, the stock has lost -5.19%. Caribou Biosciences Inc shares have fallen nearly -19.50% since the year began. Nevertheless, the stocks have fallen -81.29% over the past one year. While a 52-week high of $8.33 was reached on 01/07/25, a 52-week low of $1.22 was recorded on 02/12/25. SMA at 50 days reached $1.5772, while 200 days put it at $2.0303.
Levels Of Support And Resistance For CRBU Stock
The 24-hour chart illustrates a support level at 1.2533, which if violated will result in even more drops to 1.2267. On the upside, there is a resistance level at 1.3333. A further resistance level may holdings at 1.3867. The Relative Strength Index (RSI) on the 14-day chart is 37.24, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0245, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 77.78%. Stochastics %K at 36.61% indicates the stock is a holding.
The most recent change occurred on February 18, 2022 when RBC Capital Mkts began covering the stock and recommended ‘”an Outperform”‘ rating along with a $22 price target.
